Journal ArticleSci Adv · April 5, 2024
Fewer than 20% of triple-negative breast cancer patients experience long-term responses to mainstay chemotherapy. Resistant tumor subpopulations use alternative metabolic pathways to escape therapy, survive, and eventually recur. Here, we show in vivo, lon ...
Full textLink to itemCite
Journal ArticleMolecular cancer research : MCR · October 2023
After an initial response to chemotherapy, tumor relapse is frequent. This event is reflective of both the spatiotemporal heterogeneities of the tumor microenvironment as well as the evolutionary propensity of cancer cell populations to adapt to variable c ...
Full textCite
Journal ArticleNPJ Breast Cancer · September 26, 2022
Recurrent cancer cells that evade therapy is a leading cause of death in breast cancer patients. This risk is high for women showing an overexpression of human epidermal growth factor receptor 2 (Her2). Cells that persist can rely on different substrates f ...
Full textLink to itemCite
Journal ArticleMetabolites · April 19, 2022
Aggressive breast cancer has been shown to shift its metabolism towards increased lipid catabolism as the primary carbon source for oxidative phosphorylation. In this study, we present a technique to longitudinally monitor lipid metabolism and oxidative ph ...
Full textLink to itemCite
Journal ArticleRedox biology · February 2022
Redox metabolism plays essential functions in the pathology of cancer and many other diseases. While several radiotracers for imaging redox metabolism have been developed, there are no reports of radiotracers for in vivo imaging of protein oxidation. Here ...
Full textCite
Journal ArticleCancers (Basel) · January 5, 2021
Targeting a tumor's metabolic dependencies is a clinically actionable therapeutic approach; however, identifying subtypes of tumors likely to respond remains difficult. The use of lipids as a nutrient source is of particular importance, especially in breas ...
Full textLink to itemCite
ConferenceOptics InfoBase Conference Papers · January 1, 2020
We performed in intravital fluorescent microscopy in a preclinical cancer dormancy model to capture key changes in mitochondrial activity associated with Her2 treated breast cancer both acutely and in a residual disease state. ...
Cite
Journal Article · 2020
Targeting a tumor’s metabolic dependencies is a clinically actionable therapeutic approach, but identifying subtypes of tumors likely to respond remains difficult. The use of lipids as a nutrient source is of particular importance, especially in breast can ...
Full textCite
Journal ArticleMol Cancer Res · July 2019
With the large number of women diagnosed and treated for breast cancer each year, the importance of studying recurrence has become evident due to most deaths from breast cancer resulting from tumor recurrence following therapy. To mitigate this, cellular a ...
Full textLink to itemCite
Journal ArticleJ Biophotonics · April 2019
Therapeutically exploiting vascular and metabolic endpoints becomes critical to translational cancer studies because altered vascularity and deregulated metabolism are two important cancer hallmarks. The metabolic and vascular phenotypes of three sibling b ...
Full textLink to itemCite
Journal ArticleSci Rep · August 18, 2017
While surgery is at the foundation of cancer treatment, its access is limited in low-income countries. Here, we describe development of a low-cost alternative therapy based on intratumoral ethanol injection suitable for resource-limited settings. Although ...
Full textLink to itemCite
ConferenceOptics InfoBase Conference Papers · January 1, 2016
We have developed and utilized a wide field, high resolution microscope to capture multiple key metabolic and vascular endpoints to different indolent from metastatic disease. ...
Full textCite